Special Drug Use-results Survey for Long-term Administration of Durotep MT Patch 2.1mg/ 4.2mg/ 8.4mg/ 12.6mg/ 16.8mg

Special Drug Use-results Survey for Long-term Administration of Durotep MT Patch 2.1mg/ 4.2mg/ 8.4mg/ 12.6mg/ 16.8mg - Special Drug Use-results Survey for Long-term Administration of Durotep MT Patch 2.1mg/ 4.2mg/ 8.4mg/ 12.6mg/ 16.8mg

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000015898

Enrollment

500

Registered

2014-12-15

Start date

2010-02-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pain

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with chronic pain who are treated with Durotep MT Patch for the first time.

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

Measure	Time frame
Safety (Adverse Drug Reaction) Effectiveness	—

Secondary

Measure	Time frame
Effeciveness (Visual Analog Scale)	—

Countries

Japan

Contacts

Public ContactHirokazu Shirai

Janssen Pharmaceutical K.K. Safety Risk Management Dept

hshirai3@ITS.JNJ.com03-4411-5951

Outcome results